These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7474556)
1. Antioxidative action of the beta-adrenoceptor antagonist bopindolol and its metabolite 18-502. Aniya Y; Fong KF; Naito A; Sakanashi M Jpn J Pharmacol; 1995 Jul; 68(3):323-9. PubMed ID: 7474556 [TBL] [Abstract][Full Text] [Related]
2. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria. Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775 [TBL] [Abstract][Full Text] [Related]
3. [Beta-blocking actions and the partial agonist activity of bopindolol, a new beta-adrenoceptor antagonist, and its two metabolites]. Chin WP; Sun HT; Kawada T; Imai S Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):27-33. PubMed ID: 2571551 [TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs. Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012 [TBL] [Abstract][Full Text] [Related]
5. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol. Ishibashi T; Mitomi A; Tatebe S; Imai S Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836 [TBL] [Abstract][Full Text] [Related]
6. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR). Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963 [TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of bopindolol in pithed rats. Tanaka H; Takahashi S; Shigenobu K Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742 [TBL] [Abstract][Full Text] [Related]
8. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696 [TBL] [Abstract][Full Text] [Related]
9. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria. Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats. Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891 [TBL] [Abstract][Full Text] [Related]
11. Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers. Hosohata Y; Sasaki K; Shen Y; Hattori K; Suzuki J; Nagatomo T Biol Pharm Bull; 1995 Aug; 18(8):1066-71. PubMed ID: 8535397 [TBL] [Abstract][Full Text] [Related]
12. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. Doggrell SA; Henderson CJ J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226 [TBL] [Abstract][Full Text] [Related]
13. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162 [TBL] [Abstract][Full Text] [Related]
14. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Kaumann AJ; Molenaar P Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547 [TBL] [Abstract][Full Text] [Related]
15. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process? Aruoma OI; Smith C; Cecchini R; Evans PJ; Halliwell B Biochem Pharmacol; 1991 Jul; 42(4):735-43. PubMed ID: 1678258 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol. Aellig WH J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811 [TBL] [Abstract][Full Text] [Related]
17. Effects of (+/-)- (+)- and (-)-metoprolol, (+/-)- (+)- and (-)-pindolol, (+/-)-mepindolol and (+/-)-bopindolol on the rat left atria and portal vein. Doggrell SA Gen Pharmacol; 1991; 22(6):1169-77. PubMed ID: 1687398 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the antagonism with metoprolol, ICI 147,798, pindolol, mepindolol and bopindolol on the responses of the rat left atria to isoprenaline. Surman AJ; Doggrell SA Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec; 346(6):657-64. PubMed ID: 1362454 [TBL] [Abstract][Full Text] [Related]
19. Prevention of postischemic reperfusion damage on isolated working rat hearts by bopindolol and propranolol. Jin XZ; Liu GD Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):394-8. PubMed ID: 2575837 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Aellig WH Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]